CN108938580A
|
|
Paroxetine hydrochloride oral disintegrating tablet
|
CN108947869A
|
|
A kind of preparation method of escitalopram process impurity
|
CN108938577A
|
|
A kind of memantine freeze-drying oral disintegrating tablet and preparation method thereof
|
CN107334741A
|
|
Rivastigmine-hydrogentartrate piece of hardness and dissolution rate stabilization and preparation method thereof
|
CN107320453A
|
|
For stable rivastigmine-hydrogentartrate piece of R Rivastigmines and preparation method thereof
|
CN107334740A
|
|
For stable rivastigmine-hydrogentartrate piece of fortified phenol and preparation method thereof
|
CN106389343A
|
|
Oral aripiprazole liquid dry suspension agent and preparation method thereof
|
CN105560192A
|
|
Preparation method of paliperidone palmitate long-acting microsphere injection
|
CN105616344A
|
|
Aripiprazole injection and preparation method therefor
|
CN105254579A
|
|
Method for preparing bilastine intermediate through one-kettle process
|
CN104382896A
|
|
Pharmaceutical composition containing ezetimibe and simvastatin
|
CN104337774A
|
|
Preparation method of desloratadine granules
|
CN104337785A
|
|
Orally disintegrating tablet containing ezetimibe and preparation method of orally disintegrating tablet
|
CN104382870A
|
|
Compound containing polacrilin potassium-paroxetine
|
CN104398481A
|
|
Bilastine orally disintegrating tablet and preparing method thereof
|
CN104398512A
|
|
Bilastine-containing pharmaceutical composition and preparing method thereof
|